Enolase deficiency: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 - Enolase Deficiency is a rare genetic disorder of glucose metabolism. Partial deficiencies have been observed in several caucasian families. The deficiency is transmitted through an autosomal dominant inheritance pattern. The for Enolase 1 has been localized to Chromosome 1 in humans. Enolase deficiency, like other glycolytic enzyme deficiences, usually manifests in red blood cells as they rely entirely on anaerobic glycolysis. Enolase deficiency is associated with a spherocytic phenotype and can result in hemolytic anemia, which is responsible for the clinical signs of Enolase deficiency.
 
{{Infobox medical condition
| name            = Enolase deficiency
| synonyms        = Glycolytic enzymopathy
| field          = [[Neurology]], [[Genetics]]
| symptoms        = [[Muscle weakness]], [[Exercise intolerance]], [[Cramps]], [[Myalgia]]
| onset          = [[Childhood]] or [[Adolescence]]
| duration        = [[Chronic]]
| causes          = [[Genetic mutation]] in the [[ENO3]] gene
| risks          = [[Family history]] of the condition
| diagnosis      = [[Genetic testing]], [[Muscle biopsy]], [[Enzyme assay]]
| differential    = [[Other glycolytic enzymopathies]], [[Muscular dystrophy]]
| treatment      = [[Supportive care]], [[Physical therapy]], [[Avoidance of strenuous exercise]]
| prognosis      = [[Variable]], depending on severity
| frequency      = [[Rare]]
}}
- Enolase Deficiency is a rare genetic disorder of glucose metabolism. Partial deficiencies have been observed in several caucasian families. The deficiency is transmitted through an autosomal dominant inheritance pattern. The for Enolase 1 has been localized to Chromosome 1 in humans. Enolase deficiency, like other glycolytic enzyme deficiences, usually manifests in red blood cells as they rely entirely on anaerobic glycolysis. Enolase deficiency is associated with a spherocytic phenotype and can result in hemolytic anemia, which is responsible for the clinical signs of Enolase deficiency.
[[Category:Uncategorized
[[Category:Uncategorized
{{stb}}
{{stb}}
{{dictionary-stub1}}
{{dictionary-stub1}}
{{No image}}
{{No image}}

Latest revision as of 03:17, 4 April 2025


Enolase deficiency
Synonyms Glycolytic enzymopathy
Pronounce N/A
Specialty N/A
Symptoms Muscle weakness, Exercise intolerance, Cramps, Myalgia
Complications N/A
Onset Childhood or Adolescence
Duration Chronic
Types N/A
Causes Genetic mutation in the ENO3 gene
Risks Family history of the condition
Diagnosis Genetic testing, Muscle biopsy, Enzyme assay
Differential diagnosis Other glycolytic enzymopathies, Muscular dystrophy
Prevention N/A
Treatment Supportive care, Physical therapy, Avoidance of strenuous exercise
Medication N/A
Prognosis Variable, depending on severity
Frequency Rare
Deaths N/A


- Enolase Deficiency is a rare genetic disorder of glucose metabolism. Partial deficiencies have been observed in several caucasian families. The deficiency is transmitted through an autosomal dominant inheritance pattern. The for Enolase 1 has been localized to Chromosome 1 in humans. Enolase deficiency, like other glycolytic enzyme deficiences, usually manifests in red blood cells as they rely entirely on anaerobic glycolysis. Enolase deficiency is associated with a spherocytic phenotype and can result in hemolytic anemia, which is responsible for the clinical signs of Enolase deficiency. [[Category:Uncategorized

This article is a stub.

You can help WikiMD by registering to expand it.
Editing is available only to registered and verified users.
WikiMD is a comprehensive, free health & wellness encyclopedia.


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!